Search

everythinglearnresearchcommunity

for

Search:↓

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Androgens and other hormones affect hair growth and skin conditions like acne.

High testosterone increases heart disease risk in women with PCOS.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Ferulic acid can reduce seizures and depression-like behaviors in catamenial epilepsy by balancing hormones and brain enzyme activity.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.